CalciMedica (CALC) reporting person holds 0 shares after amendment
Jorey Chernett, a reporting person for CalciMedica, has filed an amended Schedule 13G/A, indicating that they no longer beneficially own any shares of the company's common stock as of May 19, 2026. This "exit filing" officially reports 0% ownership of the class. The amendment serves as a routine ownership update, though it does not detail the specifics of how or when the shares were disposed of.
How this was made
The 30-second read
Why it matters
This insider activity could influence investor perception, potentially causing short-term price adjustments. However, without further context, it remains a routine disclosure.
Market read
The news has limited immediate trading impact, primarily relevant to investors monitoring insider activities in biotech firms.
What to watch
Lack of detailed disposal information limits interpretation; consider broader company news and market conditions.
Background
CalciMedica recently filed an amended Schedule 13G/A indicating that a reporting person has divested all shares, resulting in 0% ownership.
Ticker impact
The recent filing indicates that CalciMedica's reporting person has divested all shares, suggesting a change in insider ownership.
Potential short-term decrease in stock price due to insider selling, but long-term impact remains uncertain without additional context.
The complete disposal of shares by an insider is noteworthy but does not necessarily indicate negative fundamentals; it could be personal financial planning.
Market effects
Limited sector impact; insider share disposal is company-specific.
Minimal regional influence; no broader market implications indicated.
Negligible
Counterpoint
Insider disposal may be routine and unrelated to company prospects; could be personal financial reasons.
Key entities
- CompanyCalciMedica
A biotech company focused on developing therapies in the life sciences sector.




